Statistics
Publications
1
Citations
15
H-Index
1
Active since
2012
Affiliations
Paolini is an author at IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola specializing in secondary resistance to imatinib, molecular pharmacology, and primary resistance form.
Publications per year
2012–2012
1
1
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation
Pier Paolo Piccaluga, Paolini, Bertuzzi et al. · Journal of Blood Medicine · 2012 · 15 citations · Full text
1–1 of 1